Bibliografisk träff 2022-10-25 Optimization of Pyrimidine Compounds as Potent JAK1 Inhibitors and the Discovery of R507 as a Clinical Candidate. Chen Y, Li H, Yen R, Heckrodt TJ, McMurtrie D, Singh R, Taylor V, Masuda ES, Park G, Payan DG. ACS Med Chem Lett · rapid-communication; journal article · DOI 10.1021/acsmedchemlett.2c00411